Natural Alternatives International (NAII)
Manufactures private-label supplements and licenses beta-alanine ingredients.
Something off on this page? Send us feedback.
Produces private-label nutritional supplements and earns ingredient, royalty, and licensing income from its beta-alanine portfolio. Its operating model combines California production and support functions with a Swiss manufacturing platform serving international customers.
Private-label Contract Manufacturing produces customized vitamins, minerals, herbs, and other nutritional products for customers selling through direct-sales organizations, e-commerce, and retail. Patent and Trademark Licensing adds direct beta-alanine ingredient sales alongside royalty and licensing income tied to CarnoSyn, SR CarnoSyn, and TriBsyn.
U.S. formulation, testing, blending, production, packaging, and stability work is based in California, while NAIE runs full-service manufacturing in Switzerland for international customers. The integrated workflow spans receiving, warehousing, laboratory controls, custom formulation, label review, and product-registration assistance.
Revenue is concentrated in a few customers and depends on their relationships and order volumes. Operations also depend on qualified raw materials, beta-alanine suppliers meeting quality requirements, regulatory and certification programs, and the Swiss platform for international fulfillment.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Mar 31, 2026Cash & short-term investments $9.2M · Total debt $65.2M · Total assets $154.9M · Shareholders' equity $63.1M
- Revenue
- $35.3M
- Operating income
- −$4.1M
- Net income
- −$4.3M
No dividends on record.
| Institutions | 36.31% | 2.28M shares | |
|---|---|---|---|
| 24 holders · as of Jun 30, 2026 | |||
| Insiders | 8.87% | 556.3K shares | |
| 6 holders · as of Mar 10, 2026 | |||
| Other | 54.82% | 3.44M shares | |
| remainder | |||
6.28M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
Caldwell Sutter Capital, Inc.Institution | 7.94% | 498,220 | as of Jun 30, 2026 |
Dimensional Fund Advisors LPInstitution | 5.35% | 335,789 | as of Jun 30, 2026 |
Morgan StanleyInstitution | 4.90% | 307,630 | as of Jun 30, 2026 |
Mink Brook Asset Management LLCInstitution | 4.68% | 293,447 | as of Jun 30, 2026 |
Renaissance Technologies LLCInstitution | 4.42% | 277,457 | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Mar 4, 2026 | Mark A. Ledoux | director, 10 percent owner, officer: CEO/Chairman | +500 | $2.77 |
| Mar 5, 2026 | Mark A. Ledoux | director, 10 percent owner, officer: CEO/Chairman | +218 | $2.75 |
| Mar 6, 2026 | Mark A. Ledoux | director, 10 percent owner, officer: CEO/Chairman | +532 | $2.80 |
| Feb 27, 2026 | Mark A. Ledoux | director, 10 percent owner, officer: CEO/Chairman | +750 | $2.83 |
| Mar 2, 2026 | Mark A. Ledoux | director, 10 percent owner, officer: CEO/Chairman | +500 | $2.79 |
Not reported.